Literature DB >> 6264388

Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates.

R Hohlfeld, R Sterz, I Kalies, K Peper, H Wekerle.   

Abstract

Chronic experimental autoimmune myasthenia gravis (EAMG) was induced in rats by immunization with acetylcholine receptor (AChR) purified from the electroplax of Torpedo californica. 35--40 days after immunization, serum anti-AChR antibody titers were about 40 nM. At this stage, electrophysiology was performed on isolated M. omohyoideus muscle-preparations from myasthenic and from normal (control) rats. For the study of the equilibrium interaction between acetylcholine (ACh) and AChR, dose-response curves were obtained by quantitative ionophoretic application of ACh to voltage-clamped end-plates. Analysis of dose-response curves yielded the following parameters: maximum end-plate conductance per unit surface gmax (EAMG) = 10.3 +/- 1.1 nS/micrometer 2, gmax (normal) = 20.2 +/- 1.8 nS/micrometer 2; apparent dissociation constant K (EAMG) = 96 +/- 5 microM, K (normal) = 58 +/- 6 microM; Hill-coefficient nH (EAMG) = 2.3 +/- 0.1, nH (normal) = 2.3 +/- 0.1. Single channel properties were derived from an analysis of ACh-induced end-plate current noise: the mean single channel conductance was gamma (EAMG) = 20.1 +/- 2.2 pS, gamma (normal) = 27.6 +/- 1.8 pS and the mean channel life-time tau (EAMG) = 1.39 +/- 0.09 ms, tau (normal) = 1.32 +/- 0.08 ms (T = 22 degrees C). The electrophysiological data are interpreted as follows: (1) At myasthenic end-plates there is a 50--60% reduction of functioning AChR (decrease of gmax). A total number of about 2 x 10(6) (1 x 10(6)) channels per end-plate was calculated for control (myasthenic) rats. (2) The affinity of AChR for ACh is reduced and/or there is an impediment of the conformational change from the closed- to the open-channel configuration (increase of K). (3) Single channel properties are essentially unaffected.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264388     DOI: 10.1007/bf00590199

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  30 in total

1.  An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.

Authors:  E X Albuquerque; J E Rash; R F Mayer; J R Satterfield
Journal:  Exp Neurol       Date:  1976-06       Impact factor: 5.330

2.  Neuromuscular transmission after immunization against acetylcholine receptors.

Authors:  D P Green; R Miledi; A Vincent
Journal:  Proc R Soc Lond B Biol Sci       Date:  1975-04-29

Review 3.  Control of acetylcholine receptors in skeletal muscle.

Authors:  D M Fambrough
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

Review 4.  Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model.

Authors:  J Lindstrom
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

5.  Acetylcholine-induced conductance fluctuations in cultured human myotubes.

Authors:  S Bevan; R W Kullberg; J Rice
Journal:  Nature       Date:  1978-06-08       Impact factor: 49.962

6.  Autoimmune rat T lymphocytes monospecific for acetylcholine receptors: purification and fine specificity.

Authors:  R Hohlfeld; I Kalies; F Heinz; J R Kalden; H Wekerle
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  End-plate potentials in experimental autoimmune myasthenia gravis in rats.

Authors:  E H Lambert; J M Lindstrom; V A Lennon
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

8.  Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-04-29       Impact factor: 47.728

9.  Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction.

Authors:  C R Anderson; C F Stevens
Journal:  J Physiol       Date:  1973-12       Impact factor: 5.182

10.  Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.

Authors:  A G Engel; J M Lindstrom; E H Lambert; V A Lennon
Journal:  Neurology       Date:  1977-04       Impact factor: 9.910

View more
  5 in total

1.  Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs.

Authors:  G Goldberg; D Mochly-Rosen; S Fuchs; Y Lass
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

2.  Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate.

Authors:  R A Maselli; D J Nelson; D P Richman
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

3.  Postjunctional characteristics of the endplates in mammalian fast and slow muscles.

Authors:  R Sterz; M Pagala; K Peper
Journal:  Pflugers Arch       Date:  1983-06       Impact factor: 3.657

4.  Physiochemical and immunological properties of acetylcholine receptors from human muscle.

Authors:  I Kalies; F Heinz; R Hohlfeld; H Wekerle; K L Birnberger; J R Kalden
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

5.  Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.

Authors:  Mario Losen; Pilar Martinez-Martinez; Peter C Molenaar; Konstantinos Lazaridis; Socrates Tzartos; Talma Brenner; Rui-Sheng Duan; Jie Luo; Jon Lindstrom; Linda Kusner
Journal:  Exp Neurol       Date:  2015-03-18       Impact factor: 5.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.